WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k ...
Hosted on MSN3mon
ZBH Stock Might Rise Following FDA Nod for Knee Implant ComponentZimmer Biomet Holdings, Inc. ZBH recently received the FDA 510(k) clearance for its Persona SoluTion Porous ... with an implant made of cobalt-chrome (Co-Cr-Mo) alloy. When exposed to certain ...
Persona Revision SoluTion Femur will be commercially available in the U.S. in Q3 2025. About Zimmer Biomet Zimmer Biomet is a global medical technology leader with a comprehensive portfolio ...
(RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH), Friday announced that the company has received the U.S. Food and Drug Administration 510(k) clearance of Persona Revision SoluTion Femur, a revision ...
2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona ...
WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) ...
8,9 Persona Revision SoluTion Femur will be commercially available in the U.S. in Q3 2025. About Zimmer Biomet Zimmer Biomet is a global medical technology leader with a comprehensive portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback